The University of California and Foundery Sign Master Agreement to Translate Novel Discoveries into Transformational Immunotherapies

Foundery Team leaders Max Krummel, Ph.D., Michel Streuli, Ph.D., and Venkataraman “Sriram”, Ph.D.

The unique industry-academic partnership supports UCSF investigator research while creating opportunities for downstream drug development and shared economics.

Learn More